Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article
Lates News:
-
Bitcoin ($BTC) Price Hitting $100,000 Is a 'Matter of Time', Says Bloomberg Analyst
-
Bloomberg Strategist on $ETH vs $BTC: “Ethereum’s Upper Hand Could Be Enduring”
-
The DRC-20 Effect: How Dogecoin Tokens Outpaced Bitcoin’s Daily Transactions
-
$BTC: Former SEC Enforcement Attorney Explains Why “Bitcoin’s Price Is Rising”
-
Why Bitcoin Evangelist Michael Saylor Stepping Down As MicroStrategy CEO Could Be A Boon For BTC